Skip to main content
. Author manuscript; available in PMC: 2014 Apr 15.
Published in final edited form as: Biochem Pharmacol. 2013 Jan 31;85(8):1171–1181. doi: 10.1016/j.bcp.2013.01.021

Table 2 .

Inhibition of A3AR binding of known AR agonists and antagonists using MRS5218 (30 nM) as a FCM tracer in whole cells.a

Compound hA3AR radioligand
binding, Ki (nM)b
FCM binding at
hA3AR, Ki(nM)
Agonists
Cl-IB-MECA 1.4 1.3±0.3
IB-MECA 1.8 2.7±0.4
NECA 25 73.6±7.9
CPA 72 88.4±13.6
Antagonists
MRS1220 0.65 5.9±0.7
XAC 13.8 17.6±3.6
a

Incubation of A3AR-expressing CHO cells with MRS5218 (30 nM) for 60 min at 37 °C was performed in the presence of 0.4 M sucrose (60 min). The inhibitors were added 15 min prior to the fluorescent tracer. Ki values represent the mean of at least three replicates.

b

Ki values for A3AR binding affinity in cell membrane preparations using [125I]I-AB-MECA are reported [16 and references therein].